NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide …

Human herpesvirus 6 (HHV-6) infects nearly 100 percent of humans in early childhood, and the infection then lasts for the rest of a person’s life. Now, a team led by Peter Medveczky, MD, a professor in the Department of Molecular Medicine at the University of South Florida, has discovered that in some individuals, HHV-6 causes such a permanent infection by inserting or “integrating” its DNA into …

Human herpesvirus 6 (HHV-6) infects nearly 100 percent of humans in early childhood, and the infection then lasts for the rest of a person’s life. Now, a team led by Peter Medveczky, MD, a professor in the Department of Molecular Medicine at the University of South Florida (USF), has discovered that in some individuals, HHV-6 causes such a permanent infection by inserting or “integrating” its …

The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health . Â The grant is designed to shrink technology found in large hospital hematology analyzers, typically the …

Genomics pioneer Leroy Hood says a coming revolution in medicine will bring enormous new opportunities. Leroy Hood has been at the center of a number of paradigm shifts in biology. He helped to invent the first automated DNA sequencing machine in the 1980s, along with several other technologies that have changed the face of molecular biology. And in 2000, he founded the Institute for Systems …

( Springer ) Beginning in 2010 Springer is adding Nuclear Medicine and Molecular Imaging to its journals publishing program. The journal will be published quarterly on behalf of the Korean Society of Nuclear Medicine, which has been the publisher of the journal since 1967.

NEW YORK (GenomeWeb News) – The newly-named founding executive director of the Virginia Tech Carilion Research Institute said it will begin operations this fall by ramping up a program in neuroscience — his longtime research focus, and a specialty of the university — to be followed over the first two years by programs in cardiovascular science and cancer.

Human herpesvirus 6 (HHV-6) infects nearly 100 percent of humans in early childhood, and the infection then lasts for the rest of a person’s life. Now, a team led by Peter Medveczky, MD, a professor in the Department of Molecular Medicine at the University of South Florida (USF), has discovered that in some individuals, HHV-6 causes such a permanent infection by inserting or “integrating” its …

Anita Tilwari (32) is in Malaysia, researching on medicinal plants for curing cancer. Having overcome two handicaps — of being a Dalit and a woman — she won a government of India fellowship for research at the Institute for Research in Molecular Medicine, University Sains Malaysia, Kelantan, north Malaysia.

Formalizing an initiative that has been at the “exploratory” stage for the last few years, IBM last week said that it is launching a new information-based medicine business unit to address the IT infrastructure needs of personalized healthcare.

Funded by a $1 million grant from the W.M. Keck Foundation, University of Chicago scientists are aiming to develop a systematic method for determining how biological processes emerge from molecular interactions. The method may permit them to “rewire” the regulatory circuitry of insulin-secreting pancreatic beta cells, which play a major role in type-2 diabetes…

( Society of Nuclear Medicine ) Registration to the world’s largest molecular imaging and nuclear medicine meeting now open — and free — for members of the media.

In an announcement today, Mount Sinai School of Medicine (MSSM) and Medisyn Technologies, Inc. said they have identified new chemical classes of preclinical compounds that may eventually lead to the first effective management of toxic amyloid aggregation and accumulation in the brain- an abnormal biological process long suspected by many researchers to be a major culprit in the onset and …

Abbott (NYSE: ABT ) announced today that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.

Abbott (NYSE: ABT) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK. GSK’s MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic) candidate is currently being evaluated as an adjuvant treatment in melanoma biopsy …

Abbott announced today that it has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level. “We hope this technique might be helpful for the early …

An imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM). The technique enables researchers to visualize tumor activity at the molecular level.

Molecular imaging technique uses ultrasound and microscopic bubbles to target cancer cellsAn imaging technique combining ultrasound and specially modified contrast agents may allow researchers to noninvasively detect cancer and show its progression, according to research published in the March issue of The Journal of Nuclear Medicine (JNM).

Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al, “Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry,” appears in the March 2010 issue of the Journal of Molecular Diagnostics. Warfarin is an …